Tagged Articles

Biomet 5 articles

Biomet denied summary judgment in latest metal hip implant trial

A favorable ruling by U.S. District Judge Robert L. Miller Jr., in litigation involving allegedly defectively designed metal-on-metal hip implants manufactured by Biomet will help move hundreds of plaintiffs in the multidistrict litigation toward either their day in court or a resolution of their claims, said Navan Ward Jr., Beasley Allen attorney and co-lead counsel for the Biomet Plaintiffs Steering Committee. The favorable rulings by Judge Miller involve two bids by Biomet to dismiss certain claims in the multidistrict litigation that alleges the company’s metal-on-metal hip implants cause injuries to patients such as metallosis, a type of metal poisoning. The ... Read More

Medical device manufacturer Biomet settles whistleblower case for $6 million

EBI LLC, a medical device manufacturer doing business as Biomet Inc. and Biomet Spine and Bone Healing Technologies, has agreed to pay the U.S. more than $6 million to resolve whistleblower allegations that it paid illegal kickbacks to boost sales of its devices and billed government health care programs for refurbished devices in violation of the U.S. False Claims Act. EBI, based in Parsippany, N.J., makes and sells bone growth stimulators, which are used to repair bone fractures that are slow to heal. The company is a subsidiary of Warsaw, Ind.-based Biomet. The $6.07-million settlement resolves in part allegations made ... Read More

Increasing number of people in U.S. getting hip replacement surgery

An estimated 7 million people in the United States – or 2 out of every 100 – have had a total knee or hip replacement, according to a Mayo Clinic study. The research was the first major study to estimate how common joint replacement has become in the United States. Dr. Daniel J. Berry, chairman of orthopedic surgery at the Mayo Clinic and author of the study, reviewed federal databases on surgeries and life expectancy trends and reported those findings this month at the American Academy of Orthopaedic Surgeons conference in New Orleans. Until now, since the United States didn’t ... Read More

Biomet to pay $56 million to settle metal-on-metal hip implant lawsuits

Medical device company Biomet Inc. has agreed to pay at least $56 million to settle multidistrict litigation (MDL) in Indiana federal court claiming its metal-on-metal hip replacement devices were defective. MDLs are special federal legal procedures designed to speed up the process of handling complex cases, such as product liability lawsuits. Biomet disputes the fact that its devices caused people harm, however it agreed to set aside the money for MDL plaintiffs who qualify. The agreement resolves the MDL, which it has been fighting since October 2012. Plaintiffs in the MDL who received either the Biomet M2a-38 or M2a-Magnum hip ... Read More

Johnson and Johnson may sell off troubled DePuy artificial hip company

Johnson & Johnson has won U.S. antitrust approval to buy Swiss medical device company Synthes Inc., but the deal hinges on Johnson & Johnson unloading its subsidiary DePuy Orthopaedics. Biomet Inc., makers of artificial joints and other orthopedic devices, has agreed to buy DePuy, a deal valued at $280 million in cash. Biomet sees the purchase of artificial joint maker DePuy as a way to greatly expand its sports, extremities and trauma business. DePuy made headlines over the past couple years when it issued a worldwide recall of its ASR XL Acetabulator hip replacement and hip resurfacing systems because of ... Read More